Retraction Note: Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts

Affiliations

¹ Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates.
² Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar.
³ Department of Biochemistry, Weill Cornell Medical College, New York, NY, USA.
⁴ Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
⁵ Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
⁶ State Key Lab of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China.
⁷ School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.
⁸ Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, 11527, Greece.
⁹ Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar. oelagnaf@hbku.edu.qa.

Mustafa T Ardah et al. BMC Complement Med Ther. 2025.

. 2025 Nov 8;25(1):421.

doi: 10.1186/s12906-025-05176-3.

¹ Department of Biochemistry, College of Medicine and Health Science, United Arab Emirates University, Al Ain, United Arab Emirates.
² Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar.
³ Department of Biochemistry, Weill Cornell Medical College, New York, NY, USA.
⁴ Basic Medical Sciences Department, College of Medicine, QU Health, Qatar University, Doha, Qatar.
⁵ Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
⁶ State Key Lab of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao, China.
⁷ School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong.
⁸ Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, Athens, 11527, Greece.
⁹ Neurological Disorders Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Education City, Qatar Foundation, P.O. Box 5825, Doha, Qatar. oelagnaf@hbku.edu.qa.

No abstract available

Retraction of

Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
Ardah MT, Ghanem SS, Abdulla SA, Lv G, Emara MM, Paleologou KE, Vaikath NN, Lu JH, Li M, Vekrellis K, Eliezer D, El-Agnaf OMA. Ardah MT, et al. BMC Complement Med Ther. 2020 Mar 6;20(1):73. doi: 10.1186/s12906-020-2849-1. BMC Complement Med Ther. 2020. Retraction in: BMC Complement Med Ther. 2025 Nov 8;25(1):421. doi: 10.1186/s12906-025-05176-3. PMID: 32143619 Free PMC article. Retracted.

1. Ardah MT, Paleologou KE, Lv G, Menon SA, Abul Khair SB, Lu JH, et al. Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils. Neurobiol Dis. 2015;74:89–101. 10.1016/j.nbd.2014.11.007. - DOI - PMC - PubMed
1. Ardah MT, Merghani MM, Haque ME. Thymoquinone prevents neurodegeneration against MPTP in vivo and modulates α-synuclein aggregation in vitro. Neurochem Int. 2019;128:115–26. 10.1016/j.neuint.2019.04.014. - DOI - PubMed
1. Ardah MT, Paleologou KE, Lv G, Abul Khair SB, Kazim AS, Minhas ST, et al. Structure activity relationship of phenolic acid inhibitors of α- Î±-synuclein fibril formation and toxicity. Front Aging Neurosci. 2014;6:197. 10.3389/fnagi.2014.00197 - DOI - PMC - PubMed